In the PanCanAtlas, KRAS mutations were widespread in PAAD (72%), COAD (45%), rectum adenocarcinoma (READ, 42%), and LUAD (31%), while NRAS mutations were common in SKCM (31%) (Figure S1A). This evidence concerns the gene NRAS and pancreatic adenocarcinoma.